Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Eli Lilly submitted the orforglipron NDA to the FDA in Q1 2026 following ATTAIN Phase 3 trial data showing 14.7% body weight reduction at 45mg positioning the worlds first oral small molecule GLP-1 receptor agonist for obesity for anticipated FDA approval in late 2026 or 2027
Basaglar vs Ozempic Cost Comparison 2026 Basaglar may seem like the more affordable option compared to Ozempic
Having beautiful skin has never been so easy
N Engl J Med 2025;392:427-437
US$ 26.76
US$ 21.30
US$ 22.56
US$ 27.55
US$ 21.04
US$ 25.32
US$ 21.61
